Promising experimental MS drug trial testing in Seattle
KING 5 Seattle Fri, 03 Aug 2007 5:25 PM PDT
An Oregon researcher may be on the verge of a huge breakthrough in treating multiple sclerosis. He has developed a new drug that appears to reverse one of the most debilitating symptoms of the disease, at least in animal studies.

I'm so leaky
Malaysia Star - Malaysia
Finally, a stroke, spinal cord injury, dementia or diseases that affect the nervous system, such as Parkinson's disease and multiple sclerosis, ...
See all stories on this topic

MS Ride: Hoping to find a cure
Shelbyville Times-Gazette - TN,USA
Multiple sclerosis (MS) is a chronic, progressive illness that affects the nerves in the brain, spinal cord, and other parts of the central nervous system. ...
See all stories on this topic

Crohn's Disease Closer to being Added to Tysabri's Label
Genetic Engineering News (press release) - New Rochelle,NY,USA
An FDA advisory panel vouched in favor of approving Tysabri for moderate-to-severe Crohn's disease in patients who have failed or cannot tolerate available ...
See all stories on this topic

Elan exit from SD is part of makeover
San Diego Union Tribune - United States
Elan and Biogen Idec, which also has a San Diego unit, are co-developers of the multiple sclerosis drug Tysabri. This week, a Food and Drug Administration ...
See all stories on this topic

US committee backs Tysabri for Crohn's
RTE.ie - Ireland
Pharmaceutical company Élan has announced that an advisory committee in the US has recommended approval of its Tysabri drug as a treatment for Crohn's ...
See all stories on this topic

FDA panel recommends Tysabri as Chron's treatment
Medical Marketing and Media - New York,NY,USA
by Stephen McGuire An FDA advisory panel voted 12-3 in favor of recommending Biogen IDEC and Elan's Tysabri for use in Crohn's disease patients, ...
See all stories on this topic